KEC International is reminding shareholders holding shares in physical form to update their KYC (Know Your Customer) details. This is in accordance with recent circulars regarding mandatory updates to PAN, address, mobile number, bank account details, and specimen signature. Shareholders are requested to provide these details to MUFG Intime India Private Limited to ensure uninterrupted dividend payments and continued access to company communications.

KYC Details Update for Physical Shareholders

KEC International urges shareholders holding shares in physical form to update their Know Your Customer (KYC) details. This request aligns with the directives emphasizing the importance of accurate and up-to-date shareholder information.

Mandatory Information

Shareholders must furnish the following information:

• PAN (Permanent Account Number)
• Address with PIN code
• Mobile Number
• Bank Account Details
• Specimen Signature

While registration of Email ID and choice of Nomination is optional, security holders are encouraged to register their email addresses and nomination details to avail online services.

Impact of Non-Compliance

Failure to update PAN, contact details (address with PIN and mobile number), bank account details, or specimen signature may result in dividend payments being made exclusively through electronic mode upon submission of all required information.

Timeline and Process

If a security holder updates their PAN, contact details including mobile number, bank account details and specimen signature after April 1, 2024, they will receive all dividends/interest declared during the period from April 1, 2024 until the date of updation, after the updation process.

Shareholders can download the necessary forms (ISR-1, ISR-2, ISR-3, SH-13, SH-14) from the registrar’s website.

Submission Methods

Shareholders can submit the required documents through one of the following methods:

• In-Person Verification (IPV): Present original documents to the authorized person of the RTA for verification (MUFG Intime).
• Post/Courier: Send self-attested copies of documents to the RTA address.
• Electronic Mode: Submit documents electronically through registered email or the RTA’s service portal, ensuring the documents are e-signed.

Shareholders holding shares in physical form are strongly encouraged to convert their holdings to demat form for enhanced market liquidity.

Source: BSE

BEML Limited has announced the appointment of Shri Sachin Dighde as the Director (Defence Business), effective September 18, 2025. Shri Dighde brings over three decades of experience, having previously served as Chief of Rolling Stock at the Ministry of Railways. This strategic move aims to strengthen BEML’s Defence Business operations and leverage Shri Dighde’s extensive expertise in engineering and strategic project management.

New Leadership in Defence Sector

BEML Limited has appointed Shri Sachin Dighde as Director (Defence Business), effective September 18, 2025. This appointment aims to bolster BEML’s capabilities in the defence sector. Shri Dighde has officially assumed his responsibilities.

Extensive Experience

Shri Sachin Dighde is an accomplished Engineer with over three decades of experience. Before joining BEML, he served as Chief of Rolling Stock at the Ministry of Railways. He is expected to bring significant experience in managing complex engineering operations and strategic projects to his new role at BEML.

Source: BSE

Jusmiral Holdings Limited, a promoter of Cohance Lifesciences, has sold 3,41,48,000 shares, reducing its stake to 24.15%. The sale occurred on September 18, 2025. The proceeds are primarily intended for part payment of borrowings under the Notes Purchase Agreement. This disclosure follows insider trading regulations and provides information regarding changes in promoter holdings.

Promoter Share Sale

Jusmiral Holdings Limited, a promoter of Cohance Lifesciences, executed a sale of shares on September 18, 2025. The transaction involved the disposal of 3,41,48,000 shares.

Revised Shareholding

Following the sale, Jusmiral Holdings Limited’s shareholding in Cohance Lifesciences has decreased to 24.15%. The company previously held 33.08% of the shares.

Use of Proceeds

The proceeds from the sale are primarily intended to be used for the partial repayment of borrowings under the Notes Purchase Agreement. The initial disclosures related to this agreement were made on May 9, 2025.

Source: BSE

The Government of India has withdrawn the nomination of Shri Sushil Kumar Singh as Nominee Director from the Board of IDBI Bank, effective September 18, 2025. This announcement confirms that Shri Sushil Kumar Singh ceases to be a Nominee Director of the Bank, as per the communication received on this date. The bank has officially recorded this change.

Board of Directors Update

IDBI Bank has announced a change concerning its Board of Directors. Effective September 18, 2025, Shri Sushil Kumar Singh’s nomination as a Nominee Director has been withdrawn.

Details of the Change

The decision to withdraw the nomination of Shri Sushil Kumar Singh was communicated via a letter from the Government of India. As a result, Shri Singh will no longer serve as a Nominee Director on the Board of IDBI Bank, with effect from September 18, 2025. The bank has duly recorded this change to ensure compliance.

Source: BSE

Aster DM Healthcare has submitted its monthly report for August 2025 regarding the special window for re-lodgement of shares. The report, in compliance with SEBI circular guidelines, confirms that there were no requests received, processed, approved, or rejected during the reporting period. The report pertains to physical share transfer requests handled by MUFG Intime India Private Limited, the Registrar and Share Transfer Agent (RTA) for the company.

August 2025 Share Re-Lodgement Summary

Aster DM Healthcare confirms the submission of its monthly report concerning the special window for re-lodgement of shares, specifically for the month of August 2025.

Key Highlights

The report indicates the following for the month of August 2025:

• No. of requests received during the month: Nil
• No. of requests processed during the month: Nil
• No. of requests approved: Nil
• No. of requests rejected: Nil
• Average time taken for processing of requests (days): NA

This report reflects the company’s adherence to regulatory requirements regarding the re-lodgement of physical share transfer requests. These requests are managed through their appointed Registrar and Share Transfer Agent (RTA), MUFG Intime India Private Limited.

Source: BSE

Sonata Software has announced a meeting with an Institutional Investor/Analyst scheduled for September 18, 2025. The meeting is a one-on-one format and will be held in Bengaluru. The discussion will focus on publicly available information, ensuring no unpublished price-sensitive information is shared. This event aims to provide investors with updated insights into the company’s performance and strategic direction.

Upcoming Investor Meeting

Sonata Software is set to host an Analyst/Investor Meet on September 18, 2025. The meeting, which will be conducted in a one-on-one format, aims to provide insights into the company’s operations and future outlook.

Meeting Details

The meeting is scheduled to take place in Bengaluru and will run from 12:00 PM to 01:00 PM (IST). It will be a physical meeting with Westwood Global Investments LLC. Only publicly available information and documents will be discussed during the interaction.

Information Accessibility

Further details regarding the Company are available on the Sonata Software website: https://www.sonata-software.com/about-us/investor-relations.

Source: BSE

DCM Shriram has addressed an inquiry regarding a recent increase in trading volume. The company confirmed that all necessary information and announcements have already been disclosed to the exchanges, adhering to regulatory guidelines. DCM Shriram stated they have no further information to add on the matter and assured the exchange of their continued compliance.

Response to Volume Inquiry

DCM Shriram has responded to an email dated 18th September 2025, concerning an increase in the company’s trading volume. The company affirms its commitment to transparency and compliance.

Confirmation of Disclosures

DCM Shriram confirms that all required information and announcements related to potential factors influencing the volume increase have been previously disclosed. The company reiterates its adherence to disclosure norms and states that all material information has already been shared with the exchanges.

No Further Information

DCM Shriram explicitly states they have no additional information to provide regarding the volume movement beyond what has already been disclosed. The company assures stakeholders of its ongoing cooperation and commitment to regulatory compliance.

Source: BSE

Bandhan Bank successfully hosted a meeting for analysts and institutional investors on September 18, 2025. The discussions, part of the BofA India Financials Forum 2025, included participation from key investment firms. The event was held virtually, providing a platform for detailed discussions on the bank’s strategy and financial outlook. A detailed list of participating firms is provided, enhancing transparency.

Analyst and Investor Engagement

Bandhan Bank convened a meeting with analysts and institutional investors on September 18, 2025, facilitating an exchange of insights and updates on the bank’s performance and strategic direction. The meeting was part of the BofA India Financials Forum 2025.

Participating Institutions

The virtual meeting included representatives from the following firms:

• Aditya Birla Sun Life AMC
• Balyasny Asset Management (HK)
• Carrhae Capital
• HSBC Asset Management (India)
• Ishana Capital
• Marshall Wace Asia
• Millennium Capital Management
• Millennium Partners, L.P.
• Nine Masts Capital
• Oxbow Capital Management (SG) Pte
• Pinpoint Asset Management
• Polymer Capital Management (HK)
• Schonfeld Strategic Advisors Llc
• Tara Capital Partners
• Tata Capital
• Triveni Capital

Source: BSE